Home Analyst Ratings KeyBanc reiterates NXP Semiconductors at Overweight and assigns price target at...

KeyBanc reiterates NXP Semiconductors [NXPI] at Overweight and assigns price target at $195

KeyBanc maintained its NXP Semiconductors [NXPI] rating to the equivalent of Overweight but changed the price target to $195 from $190, in a research note dated 2021-01-06. That figure represents around a 17.7% premium from where the company’s shares closed on Tuesday. Other analysts also revised their coverage, with Needham’s analysts reiterating the shares to “a Strong buy” rating in a research note to investors issued in early October. Meanwhile, Cowen had maintained its rating on NXPI to the earlier “an Outperform” rating, in a research note produced for clients October 09, 2020. In addition, Wells Fargo launched coverage on August 25, 2020. The research firm rated NXPI “an Overweight”.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Is NXP Semiconductors N.V. [NASDAQ:NXPI] a Good Buy Right Now?

It should be noted that NXPI technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 80% Buy in the last week and compares with 100% Buy in the past month. Data from NXP Semiconductors N.V.’s Trend Spotter indicated that the signals were Strongest. The stock current average is 1.91 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 1.97 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 1.95 million shares.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


NXPI Price Performance

On Wall Street, NXP Semiconductors N.V. [NASDAQ:NXPI] finished Tuesday’s session up 2.24% at $165.67. The stock went up to $165.965 at the same session while its lowest single day price was $161.12. In the last five days, it saw a rise of about 4.74%, NXP Semiconductors N.V. shares gained by almost 4.19% since the beginning of the year. However, the share price has dropped to as low as -0.96% below its one year high. On 01/05/21, the company shares recorded $165.96, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $158.62. The company’s shares have inclined by 31.07% in the past year. The 50-day SMA achieved is $151.93 while the 200-day SMA is $122.27. Volume dropped to 1.98 million from 2.93 million in the previous session.

NXPI Stock Support And Resistance Levels

On the 24-hour scale, the immediate backing is perceived around 162.54 level, and in case of violation of this particular level, it will cause more drop to 159.41 level. On the upper level, 169.10 is still the key resistance. The stock may increase to the subsequent resistance at 167.38. The Relative Strength Index (RSI) pinned on the 14-day chart is 66.20, implying a neutral technical stance while the MACD stands at 3.76, meaning price will increase in the next trading period. Percent R indicator moved to 2.26%, implying bullish price movement. Stochastic %K at 78.95% suggest selling the stock.

What is the short interest in NXP Semiconductors N.V.?

Short interest in the NXP Semiconductors N.V. stock has surged, increasing by 70000.0 shares to total 4.84 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 4.91 million, data from Yahoo Finance shows. The decrease of -1.45% suggests the stock saw some decreased bullish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 1.74% of the overall float for the stock.

NXP Semiconductors N.V.’s Biggest Shareholders: Who Owns NXP Semiconductors N.V. [NXPI]?

Filings by T. Rowe Price Associates, Inc. showed that the firm now holds a total of 28,906,290 shares or roughly 10.33% of the outstanding NXPI shares. This means their shares have increased by 979,415 from the 28,906,290 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, Fidelity Management & Research Co updated stake is worth $4,101,353,598. Details in the latest 13F filings reveal that Massachusetts Financial Services acquired their 0.74% stake valued at $1,533,661,485 while Artisan Partners LP cut theirs at $1,348,157,210. During the last quarter, Massachusetts Financial Services raised 70,791 of its shares in NXP Semiconductors N.V. while Artisan Partners LP sold -983,586 shares. The BlackRock Fund Advisors’s holdings currently number 7,227,482 shares at $1197376942.94. According to the firm’s last 13F report, JPMorgan Investment Management, I shares in the company at filing stood at 6,982,004 shares, roughly $1,106,089,074.

NXPI Earnings Forecast For The Current Quarter

NXP Semiconductors N.V. [NXPI] is expected to report strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $2.45B and an earnings per share of $2.09 for Dec 2020. Looking further ahead, the company is expected to report revenue of $2.3B at an EPS of $1.76 for Mar 2021. The estimates represent upside of 13.30% and 34.58% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

NXPI Earnings Estimates For The Current Year

For the financial year, NXP Semiconductors N.V. [NASDAQ:NXPI] is expected to bring in revenue of $8.57B. The returns are nearly $-310.0 million lower than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 6.06, lower than that of FY19 by -$1.49. Estimates put this year’s earnings growth at -19.70%, 34.50% for the next, and at an annual 9.40% over the next 5-year period. As for sales, forecasts are for a decrease of -3.50% in the current fiscal year and a further 13.30% over the following year.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam